Pioneering cancer research
The Masonic Samaritan Fund (MSF) has donated £47,500 to Yorkshire Cancer Research (YCR) following the Bradford Crocus Cancer Appeal, which enabled the University of Bradford’s Institute of Cancer Therapeutics (ICT) to purchase a proteomics mass spectrometer. The money will fund a technician to operate the equipment over the next four years.
It is hoped that the technician will play a vital role in discovering pioneering cancer treatments, using the machine to identify tiny amounts of proteins found in cancer cells. Researchers will then determine whether these proteins can be used as biomarkers for the early detection of cancer, targets for new therapies, or indicators of a patient’s likely response to current treatment.
‘We are incredibly grateful to the MSF for their generous support,’ said YCR chief executive Charles Rowett. ‘The grant will play an extremely important part in helping us to bring pioneering cancer treatments to the people of Yorkshire and beyond.’